Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 28 to April 1, 2022. […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 28 to April 1, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Health, Economic Impact of COVID-19 Set to Lessen in Coming Years
FRIDAY, April 1, 2022 (HealthDay News) — The health and economic impact of the COVID-19 pandemic is expected to lessen in the coming years, according to a study published online March 28 in Health Affairs.
Higher Incidence of SARS-CoV-2 Infection in Under 5s During Omicron
FRIDAY, April 1, 2022 (HealthDay News) — For children aged under 5, the incidence rate of severe acute respiratory syndrome coronavirus 2 infection was higher with the omicron variant versus the delta variant, according to a research letter published online April 1 in JAMA Pediatrics.
Early Use of COVID-19 Convalescent Plasma Cuts Hospitalization Risk
FRIDAY, April 1, 2022 (HealthDay News) — COVID-19 convalescent plasma administered to mostly unvaccinated outpatients within nine days after symptom onset reduced the risk of progression of COVID-19 leading to hospitalization, according to a study published online March 30 in the New England Journal of Medicine.
Biden to Lift Pandemic Rule Restricting Immigrants at Land Border
THURSDAY, March 31, 2022 (HealthDay News ) — An emergency health order that has curtailed immigration at U.S. land borders is expected to be lifted in late May.
CDC Lifts Warning on Cruise Ship Travel
THURSDAY, March 31, 2022 (HealthDay News) — A two-year advisory that warned Americans against going on cruises has been dropped by the U.S. Centers for Disease Control and Prevention.
New White House Website Speeds Access to Free COVID-19 Care
THURSDAY, March 31, 2022 (HealthDay News) — The Biden administration announced Wednesday that it has launched a new website that includes help for people trying to find free COVID-19 prevention and treatment quickly.
SARS-CoV-2 Vaccination Seems Safe After MIS-C
THURSDAY, March 31, 2022 (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 vaccination seems safe for patients previously diagnosed with multisystem inflammatory syndrome in children, according to a research letter published online March 28 in JAMA Network Open.
Booster Strategies After Janssen Shot Increased Protection Against Omicron
WEDNESDAY, March 30, 2022 (HealthDay News) — During a period of omicron predominance, vaccination with a single Janssen (Johnson & Johnson) dose offers lower protection than any of the booster strategies, according to research published in the March 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders